Shopping Cart
Remove All
Your shopping cart is currently empty
ASN04885796 (compound IV) is a neuroprotective, specific GPR17 agonist with an EC50=2.27 nM for GPR17-mediated GTPγS binding and can be used to study neurodegenerative diseases such as cerebral ischemia and demyelinating diseases.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $61 | - | In Stock | |
| 5 mg | $147 | - | In Stock | |
| 10 mg | $239 | - | In Stock | |
| 25 mg | $395 | - | In Stock | |
| 50 mg | $588 | - | In Stock | |
| 100 mg | $838 | - | In Stock | |
| 200 mg | $1,130 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $168 | - | In Stock |
| Description | ASN04885796 (compound IV) is a neuroprotective, specific GPR17 agonist with an EC50=2.27 nM for GPR17-mediated GTPγS binding and can be used to study neurodegenerative diseases such as cerebral ischemia and demyelinating diseases. |
| Targets&IC50 | GTPγS binding assay:2.27 nM (EC₅₀) |
| In vitro | ASN04885796 (compound IV) is a potent GPR17 agonist, exhibiting an EC₅₀ of 2.27 nM in assays measuring GTPγS binding stimulated by GPR17. ASN04885796 possesses neuroprotective effects and serves as a valuable tool for studying neurological disorders[1]. |
| Synonyms | AS-N04885796, ASN 04885796, AS N04885796 |
| Molecular Weight | 517.55 |
| Formula | C28H28FN5O4 |
| Cas No. | 1032892-26-4 |
| Smiles | O=C(NCC1OCCC1)C(C2=CC=C(F)C=C2)N(C(=O)CN3N=NC=4C=CC=CC43)C5=CC=C(OC)C=C5 |
| Relative Density. | 1.34 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (154.57 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+90% Corn Oil: 3.3 mg/mL (6.38 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.